Rare diseases
Investigational molecules
Locations
A study to evaluate the effectiveness and safety of eloralintide in adults with obesity or overweight without type 2 diabetes.
PolandA study to evaluate the effectiveness of NAV-240 in adults with moderate-to-severe hidradenitis suppurativa
PolandA study of PF-08634404 and a drug combination in adults with advanced or metastatic non-small cell lung cancer
PolandStudy of zenagamtide for weight loss and sleep improvement in patients with obesity and obstructive sleep apnea using positive airway pressure therapy
PolandStudy of inavolisib, ribociclib, and fulvestrant for patients with advanced hormone-receptor-positive, HER2-negative breast cancer.
PolandA study of YL201 and atezolizumab for patients with advanced solid tumors
PolandA study to evaluate the effectiveness and safety of remibrutinib in patients with secondary progressive multiple sclerosis
PolandA study to evaluate the effect of orforglipron on cardiovascular health in adults with atherosclerotic cardiovascular disease and/or chronic kidney disease
PolandA study of palazestrant and ribociclib compared to letrozole and ribociclib for patients with advanced ER+ HER2- breast cancer
PolandStudy of Revumenib, Cytarabine, and Fludarabine in Children with Relapsed or Refractory Acute Myeloid Leukemia
PolandA study to evaluate the safety and effects of inebilizumab in children and adolescents with immunoglobulin G4-related disease
PolandA study comparing AZD0486 after reduced chemotherapy versus standard chemotherapy in older or unfit patients with newly diagnosed large B-cell lymphoma
PolandTell us about your condition – we search every trial in Europe and connect you with the right site.
